Tristel PLC Journal of Infection Prevention: TSTL wipes study
January 24 2017 - 2:01AM
RNS Non-Regulatory
TIDMTSTL
Tristel PLC
24 January 2017
Tristel plc
("Tristel" or "the Company")
Tristel's chlorine dioxide wipes are proposed as an alternative
to traditional high-level disinfection soaking procedures published
in Journal of Infection Prevention
Tristel plc (AIM: TSTL), the manufacturer of infection
prevention, contamination control and hygiene products, announces
that a study conducted at the Centre Hospitalier Régional
Universitaire de Lille, France, compared its Trio Wipes System with
a detergent and a peracetic acid disinfectant manufactured by
Laboratoires Anios, Hellemmes, France. Anios is France's leading
infection prevention company and has recently been acquired by
Ecolab Inc. of the United States.
The study found that the wiping procedure with Tristel's
chlorine dioxide chemistry displayed more than a 5-log reduction of
four strains of bacteria in 30 seconds and a 4-log reduction of
bacterial spores in 2 minutes. The soaking procedure with peracetic
acid displayed similar results as chlorine dioxide against bacteria
but took 10 minutes to do so, and was unable to achieve a 4-log
reduction in bacterial spores.
Bacterial spores are considered to be the most resistant
organisms to disinfectants and the ability to kill them both in
high numbers and quickly is the distinguishing feature of the
highest performing products. Peracetic acid is the most widely used
high-level disinfectant throughout Europe and soaking an
instrument, rather than wiping it, is considered to be the
traditional method to disinfect a medical device. The medical
device used in the study was a flexible nasendoscope used in Ear,
Nose and Throat (ENT) departments. ENT is one of Tristel's main
niche markets within hospitals.
The study has been published in the Journal of Infection
Prevention (Noureddine Henoun Loukili, Nadine Lemaitre, Benoit
Guery, Olivier Gaillot, Dominique Chevalier and Geoffrey Mortuaire
(2017) and is titled 'Is a chlorine dioxide wiping procedure
suitable for the high-level disinfection of nasendoscopes', Journal
of Infection Prevention, pp. 1-6 DOI: 10.1177/1757177416679879).
Preliminary results of the study were reported by an RNS Reach on 1
December 2015.
The Tristel Wipes System is a unique, patented decontamination
method for non-lumened scopes and probes. It has been a very
significant sales success for the Company globally. Worldwide sales
of the Wipes System in the financial year ending June 2016 were
GBP8.7m.
Paul Swinney, CEO, comments: "We are pleased to see the
publication in a peer-reviewed journal of this significant study
comparing our Wipes System with peracetic acid, which is the most
widely used high-level disinfectant chemistry in Europe and
probably the United States also. The results affirm the key
advantages of our Wipes over alternative chemistries and
disinfection methods. These advantages are the level and speed of
kill of the most resistant organisms. This is the twenty-sixth
peer-reviewed and published scientific paper featuring Tristel
products - a body of evidence of our products' attributes that
forms one of our Company's key strengths.
"France is one of our key target markets for growth and this
study can only help with this ambition. We sell our products
through a distributor in France."
For further information please contact:
Tristel plc Tel: 01638 721 500
Paul Swinney, Chief
Executive Officer
Liz Dixon, Finance
Director
Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
finnCap Tel: 020 7600 1658
Geoff Nash/ Giles Rolls (Corporate
Finance)
Alice Lane (Corporate
Broking)
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRABJMITMBITBTR
(END) Dow Jones Newswires
January 24, 2017 02:00 ET (07:00 GMT)
Tristel (LSE:TSTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tristel (LSE:TSTL)
Historical Stock Chart
From Apr 2023 to Apr 2024